Micromet, Serono amend adecatumumab deal

MITI and Serono (SWX:SEO; SRA) amended a 2004 deal to develop adecatumumab ( MT201). Under the amended

Read the full 174 word article

How to gain access

Continue reading with a
two-week free trial.